STAT2 is an essential adaptor in USP18-mediated suppression of type I interferon signaling (original) (raw)

• Hertzog, P.J. & Williams, B.R. Fine tuning type I interferon responses. Cytokine Growth Factor Rev. 24, 217–225 (2013).
  Article CAS PubMed Google Scholar
• Schneider, W.M., Chevillotte, M.D. & Rice, C.M. Interferon-stimulated genes: a complex web of host defenses. Annu. Rev. Immunol. 32, 513–545 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Ivashkiv, L.B. & Donlin, L.T. Regulation of type I interferon responses. Nat. Rev. Immunol. 14, 36–49 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Zitvogel, L., Galluzzi, L., Kepp, O., Smyth, M.J. & Kroemer, G. Type I interferons in anticancer immunity. Nat. Rev. Immunol. 15, 405–414 (2015).
  Article CAS PubMed Google Scholar
• Borden, E.C. et al. Interferons at age 50: past, current and future impact on biomedicine. Nat. Rev. Drug Discov. 6, 975–990 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Sistigu, A. et al. Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy. Nat. Med. 20, 1301–1309 (2014).
  Article CAS PubMed Google Scholar
• Rieger, P.T. Interferon-alpha: a clinical update. Cancer Pract. 3, 356–365 (1995).
  CAS PubMed Google Scholar
• Dusheiko, G. Side effects of alpha interferon in chronic hepatitis C. Hepatology 26 (Suppl.1), S112–S121 (1997).
  Article Google Scholar
• Crow, Y.J. Aicardi-Goutières syndrome. Handb. Clin. Neurol. 113, 1629–1635 (2013).
  Article PubMed Google Scholar
• Meyer, O. Interferons and autoimmune disorders. Joint Bone Spine 76, 464–473 (2009).
  Article CAS PubMed Google Scholar
• Uzé, G., Lutfalla, G. & Mogensen, K.E. Alpha and beta interferons and their receptor and their friends and relations. J. Interferon Cytokine Res. 15, 3–26 (1995).
  Article PubMed Google Scholar
• Li, X., Leung, S., Qureshi, S., Darnell, J.E. Jr. & Stark, G.R. Formation of STAT1-STAT2 heterodimers and their role in the activation of IRF-1 gene transcription by interferon-alpha. J. Biol. Chem. 271, 5790–5794 (1996).
  Article CAS PubMed Google Scholar
• Platanias, L.C. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat. Rev. Immunol. 5, 375–386 (2005).
  Article CAS PubMed Google Scholar
• van Boxel-Dezaire, A.H., Rani, M.R. & Stark, G.R. Complex modulation of cell type-specific signaling in response to type I interferons. Immunity 25, 361–372 (2006).
  Article CAS PubMed Google Scholar
• Porritt, R.A. & Hertzog, P.J. Dynamic control of type I IFN signalling by an integrated network of negative regulators. Trends Immunol. 36, 150–160 (2015).
  Article CAS PubMed Google Scholar
• Marchetti, M. et al. Stat-mediated signaling induced by type I and type II interferons (IFNs) is differentially controlled through lipid microdomain association and clathrin-dependent endocytosis of IFN receptors. Mol. Biol. Cell 17, 2896–2909 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Schreiber, G. & Piehler, J. The molecular basis for functional plasticity in type I interferon signaling. Trends Immunol. 36, 139–149 (2015).
  Article CAS PubMed Google Scholar
• Liu, L.Q. et al. A novel ubiquitin-specific protease, UBP43, cloned from leukemia fusion protein AML1-ETO-expressing mice, functions in hematopoietic cell differentiation. Mol. Cell. Biol. 19, 3029–3038 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Schwer, H. et al. Cloning and characterization of a novel human ubiquitin-specific protease, a homologue of murine UBP43 (Usp18). Genomics 65, 44–52 (2000).
  Article CAS PubMed Google Scholar
• Malakhov, M.P., Malakhova, O.A., Kim, K.I., Ritchie, K.J. & Zhang, D.E. UBP43 (USP18) specifically removes ISG15 from conjugated proteins. J. Biol. Chem. 277, 9976–9981 (2002).
  Article CAS PubMed Google Scholar
• Malakhova, O.A. et al. UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity. EMBO J. 25, 2358–2367 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Wilmes, S. et al. Receptor dimerization dynamics as a regulatory valve for plasticity of type I interferon signaling. J. Cell Biol. 209, 579–593 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• François-Newton, V. et al. USP18-based negative feedback control is induced by type I and type III interferons and specifically inactivates interferon α response. PLoS One 6, e22200 (2011).
  Article PubMed PubMed Central CAS Google Scholar
• Zhang, X. et al. Human intracellular ISG15 prevents interferon-α/β over-amplification and auto-inflammation. Nature 517, 89–93 (2015).
  Article CAS PubMed Google Scholar
• Meuwissen, M.E. et al. Human USP18 deficiency underlies type 1 interferonopathy leading to severe pseudo-TORCH syndrome. J. Exp. Med. 213, 1163–1174 (2016).
  Article PubMed PubMed Central Google Scholar
• Ritchie, K.J. et al. Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection. Nat. Med. 10, 1374–1378 (2004).
  Article CAS PubMed Google Scholar
• Kim, K.I. et al. Enhanced antibacterial potential in UBP43-deficient mice against Salmonella typhimurium infection by up-regulating type I IFN signaling. J. Immunol. 175, 847–854 (2005).
  Article CAS PubMed Google Scholar
• Honke, N. et al. Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus. Nat. Immunol. 13, 51–57 (2011).
  Article PubMed CAS Google Scholar
• Honke, N. et al. Usp18 driven enforced viral replication in dendritic cells contributes to break of immunological tolerance in autoimmune diabetes. PLoS Pathog. 9, e1003650 (2013).
  Article PubMed PubMed Central CAS Google Scholar
• Goldmann, T. et al. USP18 lack in microglia causes destructive interferonopathy of the mouse brain. EMBO J. 34, 1612–1629 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Ketscher, L. et al. Selective inactivation of USP18 isopeptidase activity in vivo enhances ISG15 conjugation and viral resistance. Proc. Natl. Acad. Sci. USA 112, 1577–1582 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Yim, H.Y. et al. Elevated response to type I IFN enhances RANKL-mediated osteoclastogenesis in Usp18-knockout mice. J. Immunol. 196, 3887–3895 (2016).
  Article CAS PubMed Google Scholar
• Löchte, S., Waichman, S., Beutel, O., You, C. & Piehler, J. Live cell micropatterning reveals the dynamics of signaling complexes at the plasma membrane. J. Cell Biol. 207, 407–418 (2014).
  Article PubMed PubMed Central CAS Google Scholar
• Levy, D.E. & Darnell, J.E. Jr. Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. 3, 651–662 (2002).
  Article CAS PubMed Google Scholar
• Ketscher, L. & Knobeloch, K.P. ISG15 uncut: dissecting enzymatic and non-enzymatic functions of USP18 in vivo. Cytokine 76, 569–571 (2015).
  Article CAS PubMed Google Scholar
• Pellegrini, S., John, J., Shearer, M., Kerr, I.M. & Stark, G.R. Use of a selectable marker regulated by alpha interferon to obtain mutations in the signaling pathway. Mol. Cell. Biol. 9, 4605–4612 (1989).
  CAS PubMed PubMed Central Google Scholar
• Rani, M.R. et al. Characterization of beta-R1, a gene that is selectively induced by interferon beta (IFN-beta) compared with IFN-alpha. J. Biol. Chem. 271, 22878–22884 (1996).
  Article CAS PubMed Google Scholar
• Leung, S., Qureshi, S.A., Kerr, I.M., Darnell, J.E. Jr. & Stark, G.R. Role of STAT2 in the alpha interferon signaling pathway. Mol. Cell. Biol. 15, 1312–1317 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Hambleton, S. et al. STAT2 deficiency and susceptibility to viral illness in humans. Proc. Natl. Acad. Sci. USA 110, 3053–3058 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Yang, E., Wen, Z., Haspel, R.L., Zhang, J.J. & Darnell, J.E. Jr. The linker domain of Stat1 is required for gamma interferon-driven transcription. Mol. Cell. Biol. 19, 5106–5112 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Nguyen, V.P. et al. Stat2 binding to the interferon-alpha receptor 2 subunit is not required for interferon-alpha signaling. J. Biol. Chem. 277, 9713–9721 (2002).
  Article CAS PubMed Google Scholar
• Li, X., Leung, S., Kerr, I.M. & Stark, G.R. Functional subdomains of STAT2 required for preassociation with the alpha interferon receptor and for signaling. Mol. Cell. Biol. 17, 2048–2056 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Piehler, J., Roisman, L.C. & Schreiber, G. New structural and functional aspects of the type I interferon-receptor interaction revealed by comprehensive mutational analysis of the binding interface. J. Biol. Chem. 275, 40425–40433 (2000).
  Article CAS PubMed Google Scholar
• Improta, T. et al. Transcription factor ISGF-3 formation requires phosphorylated Stat91 protein, but Stat113 protein is phosphorylated independently of Stat91 protein. Proc. Natl. Acad. Sci. USA 91, 4776–4780 (1994).
  Article CAS PubMed PubMed Central Google Scholar
• Martinez-Moczygemba, M., Gutch, M.J., French, D.L. & Reich, N.C. Distinct STAT structure promotes interaction of STAT2 with the p48 subunit of the interferon-alpha-stimulated transcription factor ISGF3. J. Biol. Chem. 272, 20070–20076 (1997).
  Article CAS PubMed Google Scholar
• Brierley, M.M. & Fish, E.N. Functional relevance of the conserved DNA-binding domain of STAT2. J. Biol. Chem. 280, 13029–13036 (2005).
  Article CAS PubMed Google Scholar
• Melen, K., Kinnunen, L. & Julkunen, I. Arginine/lysine-rich structural element is involved in interferon-induced nuclear import of STATs. J. Biol. Chem. 276, 16447–16455 (2001).
  Article CAS PubMed Google Scholar
• Chawla-Sarkar, M., Leaman, D.W. & Borden, E.C. Preferential induction of apoptosis by interferon (IFN)-beta compared with IFN-alpha2: correlation with TRAIL/Apo2L induction in melanoma cell lines. Clin. Cancer Res. 7, 1821–1831 (2001).
  CAS PubMed Google Scholar
• González-Navajas, J.M., Lee, J., David, M. & Raz, E. Immunomodulatory functions of type I interferons. Nat. Rev. Immunol. 12, 125–135 (2012).
  Article PubMed PubMed Central CAS Google Scholar
• Chen, H.M. et al. Critical role for constitutive type I interferon signaling in the prevention of cellular transformation. Cancer Sci. 100, 449–456 (2009).
  Article CAS PubMed Google Scholar
• Zheng, H., Qian, J., Baker, D.P. & Fuchs, S.Y. Tyrosine phosphorylation of protein kinase D2 mediates ligand-inducible elimination of the Type 1 interferon receptor. J. Biol. Chem. 286, 35733–35741 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Yoshimura, A., Naka, T. & Kubo, M. SOCS proteins, cytokine signalling and immune regulation. Nat. Rev. Immunol. 7, 454–465 (2007).
  Article CAS PubMed Google Scholar
• Sarasin-Filipowicz, M. et al. Alpha interferon induces long-lasting refractoriness of JAK-STAT signaling in the mouse liver through induction of USP18/UBP43. Mol. Cell. Biol. 29, 4841–4851 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Zou, W. et al. Microarray analysis reveals that Type I interferon strongly increases the expression of immune-response related genes in Ubp43 (Usp18) deficient macrophages. Biochem. Biophys. Res. Commun. 356, 193–199 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Kotenko, S.V. et al. IFN-ës mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol. 4, 69–77 (2003).
  Article CAS PubMed Google Scholar
• Brierley, M.M., Marchington, K.L., Jurisica, I. & Fish, E.N. Identification of GAS-dependent interferon-sensitive target genes whose transcription is STAT2-dependent but ISGF3-independent. FEBS J. 273, 1569–1581 (2006).
  Article CAS PubMed Google Scholar
• Au-Yeung, N., Mandhana, R. & Horvath, C.M. Transcriptional regulation by STAT1 and STAT2 in the interferon JAK-STAT pathway. JAK-STAT 2, e23931 (2013).
  Article PubMed PubMed Central Google Scholar
• Park, C., Li, S., Cha, E. & Schindler, C. Immune response in Stat2 knockout mice. Immunity 13, 795–804 (2000).
  Article CAS PubMed Google Scholar
• London, N., Raveh, B. & Schueler-Furman, O. Druggable protein-protein interactions: from hot spots to hot segments. Curr. Opin. Chem. Biol. 17, 952–959 (2013).
  Article CAS PubMed Google Scholar
• Burkart, C. et al. Usp18 deficient mammary epithelial cells create an antitumour environment driven by hypersensitivity to IFN-λ and elevated secretion of Cxcl10. EMBO Mol. Med. 5, 1035–1050 (2013).
  Article PubMed CAS Google Scholar
• Colland, F. et al. Functional proteomics mapping of a human signaling pathway. Genome Res. 14, 1324–1332 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• James, P., Halladay, J. & Craig, E.A. Genomic libraries and a host strain designed for highly efficient two-hybrid selection in yeast. Genetics 144, 1425–1436 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Urbé, S. et al. Systematic survey of deubiquitinase localization identifies USP21 as a regulator of centrosome- and microtubule-associated functions. Mol. Biol. Cell 23, 1095–1103 (2012).
  Article PubMed PubMed Central Google Scholar
• Roder, F., Birkholz, O., Beutel, O., Paterok, D. & Piehler, J. Spatial organization of lipid phases in micropatterned polymer-supported membranes. J. Am. Chem. Soc. 135, 1189–1192 (2013).
  Article CAS PubMed Google Scholar
• Subach, O.M. et al. Conversion of red fluorescent protein into a bright blue probe. Chem. Biol. 15, 1116–1124 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Ritchie, K.J. et al. Dysregulation of protein modification by ISG15 results in brain cell injury. Genes Dev. 16, 2207–2212 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Boussif, O. et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. USA 92, 7297–7301 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Waichman, S. et al. Functional immobilization and patterning of proteins by an enzymatic transfer reaction. Anal. Chem. 82, 1478–1485 (2010).
  Article CAS PubMed Google Scholar
• Wedeking, T. et al. Spatiotemporally controlled reorganization of signaling complexes in the plasma membrane of living cells. Small 11, 5912–5918 (2015).
  Article CAS PubMed Google Scholar
• Arimoto, K. et al. Plakophilin-2 promotes tumor development by enhancing ligand-dependent and -independent epidermal growth factor receptor dimerization and activation. Mol. Cell. Biol. 34, 3843–3854 (2014).
  Article PubMed PubMed Central CAS Google Scholar
• Muster, B. et al. Respiratory chain complexes in dynamic mitochondria display a patchy distribution in life cells. PLoS One 5, e11910 (2010).
  Article PubMed PubMed Central CAS Google Scholar
• Sprague, B.L., Pego, R.L., Stavreva, D.A. & McNally, J.G. Analysis of binding reactions by fluorescence recovery after photobleaching. Biophys. J. 86, 3473–3495 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Sprague, B.L. & McNally, J.G. FRAP analysis of binding: proper and fitting. Trends Cell Biol. 15, 84–91 (2005).
  Article CAS PubMed Google Scholar
• Vogelsang, J. et al. A reducing and oxidizing system minimizes photobleaching and blinking of fluorescent dyes. Angew. Chem. Int. Edn Engl. 47, 5465–5469 (2008).
  Article CAS Google Scholar
• VandeVondele, S., Vörös, J. & Hubbell, J.A. RGD-grafted poly-L-lysine-graft-(polyethylene glycol) copolymers block non-specific protein adsorption while promoting cell adhesion. Biotechnol. Bioeng. 82, 784–790 (2003).
  Article CAS PubMed Google Scholar
• Sergé, A., Bertaux, N., Rigneault, H. & Marguet, D. Dynamic multiple-target tracing to probe spatiotemporal cartography of cell membranes. Nat. Methods 5, 687–694 (2008).
  Article PubMed CAS Google Scholar
• Goldman, L.A. et al. Characterization of antihuman IFNAR-1 monoclonal antibodies: epitope localization and functional analysis. J Interferon Cytokine Res. 19, 15–26 (1999).
  Article CAS PubMed Google Scholar